TP53 and lung adenocarcinoma: Depletion of AMs has been shown to reduce tumor invasiveness or growth in EGFR-mutant lung adenocarcinoma (15), KrasG12D and p53-deficient lung cancer (11), and chemically induced lung adenocarcinoma (16) mouse models.